2090-3170

International Journal of Breast Cancer

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 103 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact103 DOIs
2

Add abstracts to 17 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact17 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 328 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Influence of the Cancer Microenvironment on the Process… (10.1155/2012/756257)
Abstract References ORCID
78.10 10
2 Outcome for Patients with Triple-Negative Breast Cancer Is N… (10.1155/2012/764570)
Abstract ORCID
55.70 12
3 Drug Resistance and the Role of Combination Chemotherapy in… (10.1155/2013/137414)
ORCID
55.63 167
4 Role of Estrogen Receptor Signaling in Breast Cancer Metasta… (10.1155/2012/654698)
ORCID
54.18 146
5 Cancer Multidisciplinary Team Meetings: Evidence, Challenges… (10.4061/2011/831605)
ORCID
53.65 139
6 Large-Format Histology in Diagnosing Breast Carcinoma (10.1155/2012/618796)
Abstract References ORCID
52.42 4
7 Metabolic Syndrome Is Associated with Increased Breast Cance… (10.1155/2014/189384)
ORCID
48.49 86
8 Metastatic Breast Cancer to the Gastrointestinal Tract: Repo… (10.1155/2012/439023)
ORCID
47.58 79
9 C-Reactive Protein and Breast Cancer: New Insights from Old… (10.1155/2015/145647)
ORCID
47.44 78
10 Molecular Basis of Triple Negative Breast Cancer and Implica… (10.1155/2012/217185)
ORCID
47.16 76
11 Expression of the Classical and Nonclassical HLA Molecules i… (10.1155/2013/250435)
ORCID
45.81 67
12 Improving Outcomes from Breast Cancer in a Low-Income Countr… (10.1155/2012/423562)
ORCID
43.31 53
13 Phenotypic and Molecular Characterization of MCF10DCIS and S… (10.1155/2013/872743)
ORCID
42.90 51
14 Time-Dependent Prognostic Impact of Circulating Tumor Cells… (10.1155/2013/130470)
ORCID
42.69 50
15 Mechanisms of Resistance to Trastuzumab and Novel Therapeuti… (10.1155/2012/415170)
ORCID
42.47 49
16 Tannic Acid Preferentially Targets Estrogen Receptor-Positiv… (10.1155/2013/369609)
ORCID
42.47 49
17 Triple-Negative Breast Cancer (10.1155/2012/671684)
Abstract References
42.25 6
18 Cosmetic Outcome Assessment following Breast-Conserving Ther… (10.1155/2014/716860)
ORCID
42.03 47
19 The Role of Forkhead Box Protein M1 in Breast Cancer Progres… (10.1155/2016/9768183)
ORCID
42.03 47
20 The Complex Interaction of Matrix Metalloproteinases in the… (10.1155/2014/839094)
ORCID
41.09 43
21 Changes in Cytokines of the Bone Microenvironment during Bre… (10.1155/2012/160265)
ORCID
40.58 41
22 Why Breast Cancer Patients Seek Traditional Healers (10.1155/2012/689168)
ORCID
39.78 38
23 Pretreatment Thrombocytosis as a Prognostic Factor in Metast… (10.1155/2013/289563)
Abstract
39.78 38
24 Ductal Carcinoma<i>In Situ</i>: What the Pathologist Needs t… (10.1155/2013/914053)
ORCID
39.78 38
25 Efficacy and Safety of the All-Oral Schedule of Metronomic V… (10.1155/2014/769790)
ORCID
39.49 37
26 Synergistic Apoptotic Effect of Crocin and Paclitaxel or Cro… (10.1155/2015/139349)
ORCID
38.91 35
27 Evaluation of the Quilting Technique for Reduction of Postma… (10.1155/2015/287398)
ORCID
38.60 34
28 SEMA6D Expression and Patient Survival in Breast Invasive Ca… (10.1155/2015/539721)
ORCID
38.60 34
29 Experience of Initial Symptoms of Breast Cancer and Triggers… (10.1155/2012/908547)
ORCID
37.96 32
30 The Microenvironmental Effect in the Progression, Metastasis… (10.1155/2012/721659)
ORCID
37.63 31
31 Prognostic Significance of Tissue Inhibitor of Metalloprotei… (10.1155/2012/290854)
ORCID
36.93 29
32 Unmet Supportive Care Needs among Breast Cancer Survivors of… (10.1155/2016/7297813)
ORCID
36.93 29
33 Correlation between Fine-Needle Aspiration Cytology and Hist… (10.1155/2015/742573)
ORCID
36.56 28
34 Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progress… (10.1155/2012/502092)
ORCID
36.18 27
35 Triple-Negative Breast Cancer: An Update on Neoadjuvant Clin… (10.1155/2012/385978)
ORCID
35.78 26
36 Assessment of Factors Associated with Breast Self-Examinatio… (10.1155/2013/814395)
ORCID
35.78 26
37 Green Tea Catechin, EGCG, Suppresses PCB 102-Induced Prolife… (10.1155/2015/163591)
ORCID
35.78 26
38 Risk Factors of Lymph Edema in Breast Cancer Patients (10.1155/2013/641818)
ORCID
35.37 25
39 Incidence of Occult Carcinoma and High-Risk Lesions in Mamma… (10.1155/2012/145630)
ORCID
34.95 24
40 Age at Diagnosis and Breast Cancer Survival in Iran (10.1155/2012/517976)
ORCID
34.51 23
41 Preclinical Evaluation of Oncolytic Δ<i>γ</i><sub>1</sub>34.… (10.1155/2012/628697)
ORCID
34.51 23
42 The Value of Intraoperative Frozen Section Analysis for Marg… (10.1155/2014/715404)
ORCID
34.51 23
43 PKC<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML">… (10.1155/2012/740353)
ORCID
34.04 22
44 Management and Outcomes of Male Breast Cancer in Zaria, Nige… (10.1155/2012/845143)
ORCID
34.04 22
45 The Janus Face of Lipids in Human Breast Cancer: How Polyuns… (10.1155/2012/712536)
ORCID
33.06 20
46 RKIP Suppresses Breast Cancer Metastasis to the Bone by Regu… (10.1155/2012/124704)
ORCID
32.53 19
47 The Hedgehog Pathway Conditions the Bone Microenvironment fo… (10.1155/2012/298623)
ORCID
32.53 19
48 Staging Investigations in Breast Cancer: Collective Opinion… (10.1155/2013/506172)
ORCID
32.53 19
49 Smoking and Breast Cancer Recurrence after Breast Conservati… (10.1155/2014/327081)
ORCID
32.53 19
50 Assessment of Pathological Response of Breast Carcinoma in M… (10.1155/2015/536145)
ORCID
32.53 19